Preventing type 2 diabetes - risk identification and interventions for individuals at high risk: call for evidence

The National Institute for Health and Clinical Excellence (NICE) has been asked by the Department of Health (DH) to develop public health guidance on Prevention of type 2 diabetes: prevention of the progression of pre-diabetes to type 2 diabetes among adults in high-risk groups. A series of evidence reviews and an economic analysis are being conducted to address the key questions that are set out in the scope.

The final scope for this guidance can be found here http://guidance.nice.org.uk/PHG/Wave19/62

We would like to receive details of evidence that relates to the questions below and are outlined in the scope.

• How do the effectiveness and cost effectiveness of methods of identification and monitoring adults with impaired glucose regulation, and/or lifestyle interventions, vary between different communities or groups including vulnerable and disadvantaged groups?
• Which interventions or strategies, and which combinations of interventions or strategies, are the most effective and cost effective in preventing or delaying type 2 diabetes in adults with pre-diabetes within a given community?
• What are the barriers and facilitators that may affect the implementation, effectiveness and cost effectiveness of these interventions or strategies? (This should include any barriers and facilitators for specific groups.)

We are interested in identifying UK studies that have been published since 2000 or any ongoing research that is being conducted in the UK that relates to the review questions outlined above. We are interested in a broad range of different types of evidence. It may be quantitative or qualitative research. The studies may be published in journals, texts or monographs or be in the grey literature.

We are particularly interested in evidence that may help to better promote equality of opportunity relating to age, disability, gender, gender identity, ethnicity, religion and belief, sexual orientation or socio-economic status. Subgroups that may be missed by conventional services are of particular interest, for example people with learning difficulties, mental health problems, the prison population, travellers, refugees and recent migrants.

Please note that the following material is not eligible for consideration:

• Promotional material
• Unsubstantiated or non-evidence-based assertions of effectiveness
• Opinion pieces
• Forms with attachments of published material, or hard copy of published material.

Published material

Please send either full reference details (which are to include author/s, title, date, journal or publication details including volume and issue number and page numbers), not a PDF/WORD attachment or hard copy, using this form by 5pm Thursday 17th February 2011 to (type2diabetesprogression@nice.org.uk).

Ongoing research

If you are aware of trials/ongoing research relevant to our questions which are in progress please could you help us to identify that information by providing relevant information such as a link to a registered trial with the Cochrane Central Register of Controlled Trials (Clinical Trials).

http://mrw.interscience.wiley.com/cochrane/cochrane_clcentral_articles_fs.html

If you wish to submit academic in confidence material i.e. written but not yet published, or commercial in confidence i.e. internal documentation, please could you highlight which sections are confidential by using the highlighter function in Word.

Please send using this form any relevant evidence details by 5pm Thursday 17th February 2011 to (type2diabetesprogression@nice.org.uk).

Or alternatively to:

Melinda Kay
Project Coordinator - Centre for Public Health Excellence

National Institute for Health and Clinical Excellence
Level 1A
City Tower
Piccadilly Plaza
Manchester M1 4BD
United Kingdom

We look forward to receiving this information.

Thank you in advance for your help.